Article information
Full text is only aviable in PDF
References
[1.]
R. Agustín Flores-Franco.
Toracocentesis paliativa en países de bajos recursos.
Arch Bronconeumol, 46 (2010), pp. 339-340
[2.]
E. Cases, L. Seijo, C. Disdier, M.J. Lorenzo, R. Cordobilla, F. Sanchis, et al.
Uso del drenaje pleural permanente en el manejo ambulatorio del derrame pleural maligno recidivante.
Arch Bronconeumol, 45 (2009), pp. 591-596
[3.]
J.B. Putnam, R.W. Light, R.M. Rodríguez, R. Ponn, J.S. Olak, J.S. Pollak, et al.
A randomized comparison of indwelling pleural catheter and doxycicline pleurodesis in the management of malignant pleural effusions.
Cancer, 86 (1999), pp. 1992-1999
[4.]
A. Tremblay, G. Michaud.
Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural efusión.
Chest, 129 (2006), pp. 362-368
[5.]
A. Musani, A.R. Haas, L. Seijo, M. Wilby, D.H. Sterman.
Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.
Respiration, 71 (2004), pp. 559-566
[6.]
D.H. Sterman, A. Recio, R.G. Carroll, C.T. Gillespie, A. Haas, A. Vachani, et al.
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Clin Cancer Res, 13 (2007), pp. 4456-4466
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
